Cargando…
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody
COVID19 convalescent patient plasma units with high titer neutralizing antibody can be used to treat patients with severe disease. Therefore, in order to select suitable donors, neutralizing antibody titer against SARS CoV-2 needs to be determined. Because the neutralization assay is highly demandin...
Autores principales: | Moscato, Giovanna, Mazzetti, Paola, Lucenteforte, Ersilia, Rosellini, Alfredo, Cara, Alice, Quaranta, Paola, Mainardi, Valerio, Villa, Pietro, Focosi, Daniele, Lanza, Maria, Bianco, Irene, Mazzoni, Alessandro, Falcone, Marco, Menichetti, Francesco, Maggi, Fabrizio, Lai, Michele, Freer, Giulia, Pistello, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093006/ https://www.ncbi.nlm.nih.gov/pubmed/35262004 http://dx.doi.org/10.1016/j.jcvp.2021.100016 |
Ejemplares similares
-
Lack of neutralizing activity in nonconvalescent sera, regardless of ABO blood group and anti-A isoagglutinin titer
por: Focosi, Daniele, et al.
Publicado: (2021) -
SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responses
por: Mazzetti, Paola, et al.
Publicado: (2023) -
Clinical and Virological Response to Convalescent Plasma in a Chronic Lymphocytic Leukemia Patient with COVID-19 Pneumonia
por: Belcari, Giovanni, et al.
Publicado: (2022) -
Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission
por: Freer, Giulia, et al.
Publicado: (2016) -
Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor–recipient differences in concentration of neutralizing antibodies
por: Focosi, Daniele, et al.
Publicado: (2021)